In the spring of 2017, the U.S. Supreme Court handed down a trilogy of cases that addressed issues of venue, general personal jurisdiction and specific personal jurisdiction - see TC Heartland v. Kraft Foods, 137 S. Ct. 1514 (2017); BNSF Railway v. Tyrell, 137 S. Ct. 1549 (2017); Bristol-Myers Squibb v. Superior Court of Cal., 137 S.Ct. 1773 (2017).
This course, presented by Dechert attorneys Debra O’Gorman, Katherine Wyman, and Will Sachse, will discuss and analyze these decisions and the manner in which they have been interpreted since they came down. The Bristol-Myers Squibb decision in particular has had immediate and far-reaching implications in mass tort cases brought in states where neither the plaintiff nor defendant reside, and continued reverberations are expected. The course will delve into the factors applicable to determining whether a corporate defendant is subject to jurisdiction, and will also include practical tips for determining the proper forum to initiate a lawsuit, the preservation of jurisdictional defenses and asserting challenges to jurisdiction, including in cases pending prior to these decisions.
Debra D. O’Gorman counsels clients in product liability and mass tort litigation, particularly in product liability actions involving over-the-counter and prescription drugs. She has extensive experience in expert and fact witness development, as well as expert and fact depositions and the preparation of defense witnesses for testimony.
Ms. O’Gorman was an active member of several trial teams in cases around the country alleging injury from Tylenol use, as well as the trial team that successfully challenged a Mexican company’s attempt to have its foreign bankruptcy plan approved in the United States. She has also played a key role in cases involving claims against sovereign debtors, as well as the defense of a foreign bank. Ms. O’Gorman has successfully managed document discovery in a broad range of cases and has helped to utilize technology to bring efficiencies to the process.
Ms. O’Gorman also participated in the briefing of a summary judgment motion, the success of which was hailed as one of the most significant products liability rulings of 2010. In that case, the court ruled that plaintiff’s experts failed to pass the Frye test and dismissed plaintiff’s claims.
Ms. O'Gorman was a member of the Dechert litigation team recognized as part of the Financial Times’ 2013 Top U.S. Innovative Law Firms for their “standout” work acting as lead counsel for an ad hoc group of creditors in connection with the highly contested cross-border restructuring of approximately $1.6 billion in defaulted senior notes issued by Mexico's largest glass manufacturer, Vitro S.A.B. de C.V. This precedent-setting case marked the first time that U.S. courts clarified the standards and requirements for global businesses that file for Chapter 15 bankruptcy. In 2014, she was also a member of the team “highly commended” by the Financial Times’ Top 40 North American Innovative Law Firms for their representation of Argentina’s two largest creditors – with combined claims for over US$3.5 billion – in multi-national litigation and judgment enforcement proceedings. The matter concluded in a victory before the Supreme Court of the United States.
Ms. O'Gorman presented the sole witness in a trial that resulted in an $85 million judgment on behalf of creditors of the Democratic Republic of Congo in a lawsuit to recover on defaulted sovereign debt and in the fall of 2014 she acted as the primary trial attorney for a creditor/objector in the City of Detroit bankruptcy proceeding.
Ms. O'Gorman is also actively committed to pro bono initiatives. She heads the firm’s involvement in a program to provide legal advice to litigants in family court throughout New York City and has received pro bono awards from several organizations.
Will Sachse’s practice focuses on defending product liability and consumer fraud claims, as well as antitrust and commercial litigation. Mr. Sachse has worked with clients in a myriad of industries on disputes involving pharmaceuticals, biologics, medical devices, chemicals, asbestos, forest products, building products, tobacco, consumer products, telecommunications, airlines, and sovereign debt.
Mr. Sachse has been recognized by The Legal 500 United States since 2013 for his product liability and mass tort defense practice within the pharmaceuticals and medical devices industry. In 2011, Mr. Sachse was named by Law360 as one of five product liability lawyers under 40 to watch.
Mr. Sachse has lectured on defeating consumer fraud and class action claims, has served as a panelist for The American Law Journal’s Law TV, and has written articles and blog posts on issues relating to consumer fraud, products liability, and class actions.
Katherine Wyman focuses her practice on litigation matters, with a particular emphasis on complex commercial litigation, securities litigation and government investigations. Ms. Wyman’s experience also includes employment and bankruptcy matters. She represents individuals and companies in the financial services, technology, and life sciences industries.
Yale College, B.A., 2007, magna cum laude, with Distinction in the Literature and International Studies majors
Harvard Law School, J.D., 2010, cum laude, Executive Editor of the Harvard Journal of Law & Gender
United States District Court for the District of Columbia
United States Court of Appeals for the Second Circuit
United States Court of Appeals for the Eleventh Circuit
United States Court of Appeals for the District of Columbia
District of Columbia
intelligent fast moving
Very clear and well-edited presentation!
Very interesting and timely. Thanks.
Excellent summary of PJ
Great overview of this rapidly developing area
Presenters O'Gorman, Sachse and Wyman worked very well together and gave a clear and concise presentation. Thank you to each of them and to LAWLINE for a first-rate program!
Very good thank you
Excellent presentation of new jurisdictional rules and developing areas in jurisdiction.
Great stuff, might want to consider an hour and half next time since this stuff can be dense.
Unlimited CLE Subscription gives you access to take almost any course from our catalog and earn as much CLE credit as you need.